Leadership Series: Telemedicine Post-COVID-19, Hospital at Home and Expansion of Technology–April 29

Time: 11:00 AM

Location:

Webinar - 11 am to noon

Registration:

“Telemedicine Post-COVID-19, Hospital at Home and Expansion of Technology” is the first of five complimentary webinars in IHA's virtual speaker series from April through August. You may register for individual session(s) or the entire series. Registration includes program material, one phone/Internet connection and access to the session recording(s).

Register Online

Healthcare in your pocket: Once a radical concept, it’s now more attainable than ever. COVID-19 has catalyzed healthcare innovation and delivery, making it possible for diverse patients to access and communicate with providers in new ways. We’ll explore the long-term implications of telemedicine for remote patient monitoring, prevention, diagnostics and therapy. Your organization pivoted to telehealth in a time of crisis—now find out how to scale these rapid changes for lasting success.

Who Should Attend

This virtual speaker series is designed especially for hospital and health system leadership teams, including:

  • CEOs, CFOs and COOs

  • CMOs and CNOs

  • Chief human resource officers

  • Chief strategy officers

  • Chief quality officers

  • Clinical leaders

  • Department leaders

Speakers

Daniel Kraft, MD, Physician-Scientist, Healthcare Futurist
Dr. Kraft is a Stanford- and Harvard-trained physician-scientist, inventor, entrepreneur and innovator with over 25 years of experience in clinical practice, biomedical research and healthcare innovation. He has chaired the Medicine and Neuroscience track at Singularity University, a Deloitte partner, since its inception in 2008. Dr. Kraft is also the founder and chair of Exponential Medicine, a Singularity program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. He has multiple scientific publications and patents in medical device, immunology and stem cell-related topics through faculty positions at Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco.